La maladie de Parkinson au Canada (serveur d'exploration) - Checkpoint (PubMed)

Index « MedMesh.i » - entrée « Dopamine Agonists »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Dopamine Agents < Dopamine Agonists < Dopamine Antagonists  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 72.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000206 (2016) I. Aracil-Bola Os [Canada] ; A P Strafella [Canada]Molecular imaging and neural networks in impulse control disorders in Parkinson's disease.
000310 (2016) Serdar Durdagi [Turquie] ; Ramin Ekhteiari Salmas [Turquie] ; Matthias Stein [Allemagne] ; Mine Yurtsever [Turquie] ; Philip SeemanBinding Interactions of Dopamine and Apomorphine in D2High and D2Low States of Human Dopamine D2 Receptor Using Computational and Experimental Techniques.
000353 (2015) James A G. Crispo [Canada] ; Yannick Fortin ; Dylan P. Thibault ; Matthew Emons ; Lise M. Bjerre ; Dafna E. Kohen ; Santiago Perez-Lloret ; Donald Mattison ; Allison W. Willis ; Daniel KrewskiTrends in inpatient antiparkinson drug use in the USA, 2001-2012.
000394 (2015) Tanja Tran [Canada] ; James M. Brophy [Canada] ; Samy Suissa [Canada] ; Christel Renoux [Canada]Risks of Cardiac Valve Regurgitation and Heart Failure Associated with Ergot- and Non-Ergot-Derived Dopamine Agonist Use in Patients with Parkinson's Disease: A Systematic Review of Observational Studies.
000419 (2015) Alberto J. Espay [États-Unis] ; Matthew M. Norris [États-Unis] ; James C. Eliassen [États-Unis] ; Alok Dwivedi [États-Unis] ; Matthew S. Smith [États-Unis] ; Christi Banks [États-Unis] ; Jane B. Allendorfer [États-Unis] ; Anthony E. Lang [États-Unis] ; David E. Fleck [États-Unis] ; Michael J. Linke [États-Unis] ; Jerzy P. Szaflarski [États-Unis]Placebo effect of medication cost in Parkinson disease: a randomized double-blind study.
000422 (2015) Michele Tinazzi ; Alfonso Fasano ; Christian Geroin ; Francesca Morgante ; Roberto Ceravolo ; Simone Rossi ; Astrid Thomas ; Giovanni Fabbrini ; Annarita Bentivoglio ; Filippo Tamma ; Giovanni Cossu ; Nicola Modugno ; Mario Zappia ; Maria Antonietta Volontè ; Carlo Dallocchio ; Giovanni Abbruzzese ; Claudio Pacchetti ; Roberto Marconi ; Giovanni Defazio ; Margherita Canesi ; Antonino Cannas ; Antonio Pisani ; Rina Mirandola ; Paolo Barone ; Carmine VitalePisa syndrome in Parkinson disease: An observational multicenter Italian study.
000436 (2015) Philip Seeman [Canada]Parkinson's disease treatment may cause impulse-control disorder via dopamine D3 receptors.
000532 (2015) Mariano Serrao [Italie] ; Alberto Ranavolo [Italie] ; Carmela Conte [Italie] ; Chiara Davassi [Italie] ; Silvia Mari [Italie] ; Alfonso Fasano [Canada] ; Giorgia Chini [Italie] ; Gianluca Coppola [Italie] ; Francesco Draicchio [Italie] ; Francesco Pierelli [Italie]Effect of 24-h continuous rotigotine treatment on stationary and non-stationary locomotion in de novo patients with Parkinson disease in an open-label uncontrolled study.
000536 (2015) Paolo Solla [Italie] ; Alfonso Fasano [Canada] ; Antonino Cannas [Italie] ; Cesare Salvatore Mulas [Italie] ; Maria Giovanna Marrosu [Italie] ; Anthony E. Lang [Canada] ; Francesco Marrosu [Italie]Dopamine agonist withdrawal syndrome (DAWS) symptoms in Parkinson's disease patients treated with levodopa-carbidopa intestinal gel infusion.
000546 (2015) Mateusz Zurowski [Canada] ; Jonathan Darcy O'BrienDevelopments in impulse control behaviours of Parkinson's disease.
000584 (2015) María Sierra [Espagne] ; Sébastien Carnicella [France] ; Antonio P. Strafella [Canada] ; Amélie Bichon [France] ; Eugénie Lhommée [France] ; Anna Castrioto [France] ; Stephan Chabardes [France] ; Stéphane Thobois [France] ; Paul Krack [France]Apathy and Impulse Control Disorders: Yin & Yang of Dopamine Dependent Behaviors.
000656 (2014) Donald A. Mcafee [Canada] ; Jonathan Hadgraft [Royaume-Uni] ; Majella E. Lane [Royaume-Uni]Rotigotine: the first new chemical entity for transdermal drug delivery.
000658 (2014) Camila C. Aquino [Brésil] ; Tiago Mestre [Canada] ; Anthony E. Lang [Canada]Restless genital syndrome in Parkinson disease.
000659 (2014) Thomas J. Moore [États-Unis] ; Joseph Glenmullen [États-Unis] ; Donald R. Mattison [Canada]Reports of pathological gambling, hypersexuality, and compulsive shopping associated with dopamine receptor agonist drugs.
000681 (2014) Ronald B. Postuma [Canada] ; Roger L. AlbinPlacebo: from belief to movement.
000718 (2014) Anthony E. Lang [Canada] ; Connie Marras [Canada]Initiating dopaminergic treatment in Parkinson's disease.
000728 (2014) Franziska Maier [Allemagne] ; Josuah Merkl [Allemagne] ; Anna L. Ellereit [Allemagne] ; Catharine J. Lewis [Allemagne] ; Carsten Eggers [Allemagne] ; David J. Pedrosa [Allemagne] ; Elke Kalbe [Allemagne] ; Jens Kuhn [Allemagne] ; Thomas D. Meyer [Royaume-Uni] ; Mateusz Zurowski [Canada] ; Lars Timmermann [Allemagne]Hypomania and mania related to dopamine replacement therapy in Parkinson's disease.
000753 (2014) Francesca Antonelli [Canada] ; Ji Hyun Ko ; Janis Miyasaki ; Anthony E. Lang ; Sylvain Houle ; Franco Valzania ; Nicola J. Ray ; Antonio P. StrafellaDopamine-agonists and impulsivity in Parkinson's disease: impulsive choices vs. impulsive actions.
000922 (2013) Abdul Qayyum Rana [Canada] ; Wasim Mansoor ; Syed Hussaini ; Abdullah Al Mosabbir ; Maniza Rahman ; Labiba RahmanFactors associated with the development of impulse compulsive disorders in Parkinson patients.
000945 (2013) Margarita Pondal [Canada] ; Connie Marras ; Janis Miyasaki ; Elena Moro ; Melissa J. Armstrong ; Antonio P. Strafella ; Binit B. Shah ; Susan Fox ; L K Prashanth ; Nicolas Phielipp ; Anthony E. LangClinical features of dopamine agonist withdrawal syndrome in a movement disorders clinic.
000A74 (2012) Nicola J. Ray [Canada] ; Janis M. Miyasaki ; Mateusz Zurowski ; Ji Hyun Ko ; Sang Soo Cho ; Giovanna Pellecchia ; Francesca Antonelli ; Sylvain Houle ; Anthony E. Lang ; Antonio P. StrafellaExtrastriatal dopaminergic abnormalities of DA homeostasis in Parkinson's patients with medication-induced pathological gambling: a [11C] FLB-457 and PET study.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PubMed/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i -k "Dopamine Agonists" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i  \
                -Sk "Dopamine Agonists" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Dopamine Agonists
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022